Division News

Lyman on changes in breast cancer treatments

Gary Lyman, MD, MPH, professor of medicine (Medical Oncology), on camera at the San Antonio Breast Cancer Symposium in December talking about the BOLERO-2 trial as a potentially practice-changing development in the field of breast cancer. He added that more agents are needed for the treatment of advanced metastatic disease.

Putting Trials to the Test

Duke Magazine feature on Avastin: While a doctor's own experience is one guide to medical care, the evidence from clinical trials may be a better guide. But how much better? With quotes from Gary Lyman, Kim Blackwell, Robert Harrington and Eric Peterson of the Department of Medicine.

DOM faculty honored at Spring Faculty Meeting

At the Spring Faculty Meeting May 4th at the Duke Gardens, the following Medicine faculty were honored with awards:

William Kane, MD, PhD, associate professor of medicine (Hematology), received the 2011 Leonard Palumbo, Jr. MD Faculty Achievement Award, which recognizes a member of the School of Medicine faculty who displays dedication to compassionate patient care and excellence in the teaching and mentoring of young physicians.